Eltrombopag olamine and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eltrombopag olamine (eltrombopag olamine) and Cyclophosphamide (cyclophosphamide). Common drug interactions include haemorrhage among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Eltrombopag olamine and Cyclophosphamide. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Eltrombopag olamine?

Eltrombopag olamine has active ingredients of eltrombopag olamine. eHealthMe is studying from 3,901 Eltrombopag olamine users. Check the latest studies of Eltrombopag olamine.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

On Jul, 11, 2026

70 people who take Eltrombopag olamine and Cyclophosphamide together, and have interactions are studied.

Eltrombopag olamine and Cyclophosphamide drug interactions.

What are the common drug interactions of Eltrombopag Olamine and Cyclophosphamide, by gender? *:

female:

Haemorrhage (bleeding)
Drug ineffective
Red blood cell count decreased
Platelet count decreased
Blindness
Hepatitis g
Monoparesis (one limb is very weak, but not completely paralyzed)
Paraparesis (partial paralysis of the lower limbs)

male:

Platelet count decreased
Platelet count increased
Anaemia (lack of blood)
Angioimmunoblastic t-cell lymphoma (mature t-cell cancer of the blood or lymph vessel)
Cytogenetic abnormality
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pyrexia (fever)
Full blood count decreased
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Adenoviral haemorrhagic cystitis

What are the common drug interactions of Eltrombopag Olamine and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Adenoviral haemorrhagic cystitis
Blindness
Haematuria (presence of blood in urine)
Hepatitis g
Monoparesis (one limb is very weak, but not completely paralyzed)
Nephrolithiasis (calculi in the kidneys)
Paraparesis (partial paralysis of the lower limbs)
Platelet count decreased
Pyrexia (fever)

50-59:

Renal failure (kidney dysfunction)
Overdose
Drug ineffective
Haemorrhage (bleeding)
Red blood cell count decreased
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Cardiac failure
Chimerism (fertilization of two separate ova by two sperm)

60+:

Platelet count decreased
Platelet count increased
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Pulmonary oedema (fluid accumulation in the lungs)
Anaemia (lack of blood)
Angioimmunoblastic t-cell lymphoma (mature t-cell cancer of the blood or lymph vessel)
Cytogenetic abnormality
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 28 people, 40.00%
High Blood Pressure: 28 people, 40.00%
Haematotoxicity (toxins that destroy red blood cells): 28 people, 40.00%
Anaemia (lack of blood): 28 people, 40.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 27 people, 38.57%
Thrombocytopenic Purpura (a bleeding disorder in which the immune system destroys platelets): 21 people, 30.00%

* Approximation only. Some reports may have incomplete information.

Do you take Eltrombopag olamine and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously